Swissmedic issues new guideline on generics
This article was originally published in SRA
Executive Summary
Swissmedic has issued a new guideline on the authorisation of generics, effective 1 October1. In assessing generic applications, Swissmedic will in future take into account international guidelines, especially those of the European Medicines Agency, in addition to national therapeutic product requirements.